Lecture

Ethical Dimensions of Vaccine Distribution

Graph Chat

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

In course

BIO-455: Introduction to law and ethics

The aim of this course is to introduce students to the basic legal and ethical concepts relevant to research in the life sciences and its translational application, and to provide them with the essential tools to identify legal and ethical issues in their ...

Description

This lecture discusses the stark inequalities in COVID-19 vaccine distribution between rich and poor countries, highlighting the challenges faced by low-income nations. It explores the impact of booster doses in high-income countries and the lack of access to vaccines in developing nations. The presentation delves into the ethical implications of vaccine distribution, patent networks, and the role of pharmaceutical companies. It also addresses the importance of transparency in clinical trials, the need for sharing vaccine technology, and the ethical considerations surrounding drug pricing and research costs. The lecture concludes by advocating for fair pricing, transparency, and legal solutions to address the issues of patent abuse and high drug costs.

Official source

Related concepts (32)

Vaccine

A vaccine is a biological preparation that provides active acquired immunity to a particular infectious or malignant disease. The safety and effectiveness of vaccines has been widely studied and verified.

MRNA vaccine

An mRNA vaccine is a type of vaccine that uses a copy of a molecule called messenger RNA (mRNA) to produce an immune response. The vaccine delivers molecules of antigen-encoding mRNA into immune cells, which use the designed mRNA as a blueprint to build foreign protein that would normally be produced by a pathogen (such as a virus) or by a cancer cell. These protein molecules stimulate an adaptive immune response that teaches the body to identify and destroy the corresponding pathogen or cancer cells.

COVID-19 vaccine

A COVID19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID19). Prior to the COVID19 pandemic, an established body of knowledge existed about the structure and function of coronaviruses causing diseases like severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). This knowledge accelerated the development of various vaccine platforms during early 2020.

Polio vaccine

Polio vaccines are vaccines used to prevent poliomyelitis (polio). Two types are used: an inactivated poliovirus given by injection (IPV) and a weakened poliovirus given by mouth (OPV). The World Health Organization (WHO) recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 33 in 2018. The inactivated polio vaccines are very safe.

Patent

A patent is a type of intellectual property that gives its owner the legal right to exclude others from making, using, or selling an invention for a limited period of time in exchange for publishing an enabling disclosure of the invention. In most countries, patent rights fall under private law and the patent holder must sue someone infringing the patent in order to enforce their rights. The procedure for granting patents, requirements placed on the patentee, and the extent of the exclusive rights vary widely between countries according to national laws and international agreements.

Related lectures (64)

Immunology at SARS-CoV-2

Explores the immune response to Covid-19, vaccine development, and severe symptoms, emphasizing the role of ACE2 and innate immunity.

Design of Immunogenic Vaccines

Explores the design of immunogenic vaccines, boosting immune response through various methods, and addressing challenges in vaccine development.

Treatments and Vaccines MOOC: Introduction to immunology (part 2)

Discusses treatments, vaccines, and the importance of prevention against severe forms of Covid-19.

Untitled

COVID-19: Virological Situation, Variants, and Vaccine Technologies